Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study
- PMID: 17306006
- DOI: 10.1111/j.1651-2227.2007.00191.x
Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study
Abstract
Objective: To evaluate the efficacy of the probiotic yeast Saccharomyces boulardii (S. boulardii) as an adjuvant to oral rehydration solution (ORS) in shortening the duration of acute infectious gastroenteritis in children less than 2 years old in ambulatory care.
Materials and methods: In a period of 1 year, 100 outpatients between 3 and 24 months old presenting with acute mild to moderate diarrhoea of less than 7 days duration, were included in a double-blind, randomized, placebo-controlled trial evaluating the efficacy of S. boulardii administered for 6 days. Twelve children were lost in follow-up; the data of 88 children could be analysed (44 in the placebo and 44 in the S. boulardii group). Seventy-two patients were followed for one month (37 in the placebo and 35 in the S. boulardii group) allowing the calculation of the duration of diarrhoea.
Results: The mean duration of diarrhoea was 6.16 days (range 2-13 days) in the placebo group and 4.70 days (range 2-10 days) in the S. boulardii group (p<0.05). On the 4th day, the patients in the S. boulardii group passed 2.5+/-1.4 stools/day versus 3.5+/-1.8 in the placebo group (p<0.001). The risk of having diarrhoea lasting more than 7 days was lower in the S. boulardii group (3/44 versus 12/44; RR 0.25; 95% CI 0.1-0.8). In no patient diarrhoea persisted longer than 14 days. A statistically significant difference was observed in the number of stools on the 4th and 7th day favouring the subgroup that received early treatment (within the first 48 h of the onset of diarrhoea). The administration of antibiotics before inclusion did not make any difference.
Conclusion: S. boulardii as an adjuvant to ORS in ambulatory care in children less than 2 years old with mild or moderate acute diarrhoea decreased the duration of diarrhoea, accelerated recovery and reduced the risk of prolonged diarrhoea. The data also indicate increased efficacy if S. boulardii is administered within the first 48 h of the onset of diarrhoea.
Similar articles
-
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.Aliment Pharmacol Ther. 2005 Mar 1;21(5):583-90. doi: 10.1111/j.1365-2036.2005.02356.x. Aliment Pharmacol Ther. 2005. PMID: 15740542 Clinical Trial.
-
Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.Aliment Pharmacol Ther. 2007 Feb 1;25(3):257-64. doi: 10.1111/j.1365-2036.2006.03202.x. Aliment Pharmacol Ther. 2007. PMID: 17269987
-
Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study.Am J Trop Med Hyg. 2008 Feb;78(2):214-6. Am J Trop Med Hyg. 2008. PMID: 18256417 Clinical Trial.
-
[Probiotics, prebiotics and zinc in the therapy and prevention of acute infectious diarrhoea in children: state of the art].Minerva Pediatr. 2007 Dec;59(6):775-86. Minerva Pediatr. 2007. PMID: 17978787 Review. Italian.
-
Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries.Evid Based Child Health. 2013 Jul;8(4):1123-37. doi: 10.1002/ebch.1932. Evid Based Child Health. 2013. PMID: 23877938 Review.
Cited by
-
Diagnostic value of the Vesikari Scoring System for predicting the viral or bacterial pathogens in pediatric gastroenteritis.Korean J Pediatr. 2016 Mar;59(3):126-31. doi: 10.3345/kjp.2016.59.3.126. Epub 2016 Mar 31. Korean J Pediatr. 2016. PMID: 27186219 Free PMC article.
-
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.Paediatr Drugs. 2015 Jun;17(3):199-216. doi: 10.1007/s40272-015-0124-6. Paediatr Drugs. 2015. PMID: 25799959 Free PMC article.
-
The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.Eur J Clin Nutr. 2015 Mar;69(3):385-91. doi: 10.1038/ejcn.2014.238. Epub 2014 Nov 5. Eur J Clin Nutr. 2015. PMID: 25369827 Clinical Trial.
-
Probiotics for treating acute infectious diarrhoea.Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003048. doi: 10.1002/14651858.CD003048.pub3. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2020 Dec 8;12:CD003048. doi: 10.1002/14651858.CD003048.pub4. PMID: 21069673 Free PMC article. Updated.
-
Saccharomyces boulardii in childhood.Eur J Pediatr. 2009 Mar;168(3):253-65. doi: 10.1007/s00431-008-0879-7. Epub 2008 Dec 19. Eur J Pediatr. 2009. PMID: 19096876 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical